Adagio Medical Holdings Cash Flow Statement (2023-2026) | ADGM

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -9.56M-5.91M-9.57M-7.42M-4.69M-7.89M-5.33M-6.39M-4.61M-5.87M
Depreciation and Depletion (Quarter) 0.10M0.10M0.30M0.30M0.20M0.30M0.20M0.50M0.20M0.20M
Share-based Compensation (Quarter) 0.11M0.11M0.11M0.22M0.23M0.14M0.89M0.39M
Gains from Investment Securities (Quarter) 0.02M-0.09M0.08M-0.09M0.01M0.01M-0.04M0.14M0.23M-0.35M3.67M
Asset Writedowns and Impairment (Quarter) 0.00M0.08M-0.04M-0.01M
Non-cash Items (Quarter) 0.07M0.54M0.07M2.00M5.70M5.20M
Cash from Operations (Quarter) -7.09M-6.70M-6.48M-6.40M-7.20M-4.14M-4.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M0.01M
Depreciation & Amortization (CF) (Quarter) 0.10M0.13M0.33M0.32M0.32M0.27M0.20M0.50M0.24M0.21M
Change in Working Capital
Change in Receivables (Quarter) -0.00M-0.07M0.13M-0.01M-0.03M-0.00M0.02M
Change in Inventory (Quarter) 3.03M0.28M1.04M0.13M-0.26M0.12M-0.07M
Change in Account Payables (Quarter) 0.88M1.94M-0.36M-0.19M0.06M0.14M
Change in Accured Expenses (Quarter) -0.22M0.68M0.96M-0.65M-0.58M-1.50M0.14M
Other Working Capital Changes (Quarter) -0.04M-0.04M-0.02M-0.02M-0.06M-0.88M0.02M
Investing Activities
Capital Expenditures (Quarter) -0.31M0.16M0.00M0.58M0.34M-0.49M0.00M
Cash from Investing Activities (Quarter) -0.02M-0.16M-0.00M-0.58M-0.34M0.49M-0.00M
Financing Activities
Cash from Financing Activities (Quarter) 6.58M9.57M5.07M
Additional items
Exchange Rate Effect (Quarter) -0.07M0.03M0.12M0.04M-0.08M-0.06M-0.07M
Change in Cash (Quarter) -0.60M2.70M8.29M-6.89M-7.62M12.43M-4.20M
Free Cash Flow (Quarter) -6.79M-6.86M-6.49M-6.98M-7.54M-3.65M-4.10M
Net Cash Flow (Quarter) -0.53M2.71M-1.41M-6.98M-7.54M-3.65M-4.10M